AAV Production
Bockstael, O, K.Foust, B.Kaspar and L.Tenenbaum (2011). Recombinant AAV delivery to the central nervous system. Methods Mol Biol. 807:159-77. Adeno-Associated Virus: Methods and Protocols. eds. R.Snyder and P.Moullier (Humana Press) Chapter 7. ISSN: 1064-3745, OCLC: 24839341
Lock, M., S. McGorray, A.Auricchio, E. Ayuso, E. J. Beecham, V Blouin-Tavel, M F Bosch-Tubert, M Bose, B Byrne, T Caton, J Chiorini, A Chtarto, K. R Clark , Ts Conlon, C Darmon, M Doria, A Douar, T Flotte, J D. Francis, M.Giacca, M T. Korn, I Korytov, X Leon, B Leuchs, G Kroener-Lux, C Melas, Hi Mizukami, P Moullier, M Müller, K Ozawa, T Philipsberg, K Poulard, C Raupp, C Rivière, S D Roosendaal, R. J Samulski, S M. Soltys, R Surosky, L Tenenbaum, D L. Thomas, B van Montfort, G Veres, J. F Wright, Y Xu, O Zelenaia, L Zentilin and R O Snyder.(2010). Characterization of a Recombinant Adeno-Associated Virus Type 2 Reference Standard Material. Hum. Gene Ther 21:1273-85
Tenenbaum, L., E.Lehtonen and P.Monahan (2003). Evaluation of risks related to the use of adeno-associated virus-based vectors.
Curr. Gene Ther. 3: 545-565
Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ Jr, Chiodo VA, Phillipsberg T, Muzyczka N, Hauswirth WW, Flotte TR, Byrne BJ, Snyder RO (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28(2):158-67
Tenenbaum, L., M.Hamdane, M.Pouzet, B.Avalosse, A.Stathopoulos, F.Jurysta, C.Rosenbaum, C.O.Hanemann, M.Levivier and T.Velu (1999). Cellular contaminants of adeno-associated virus vector stocks can enhance transduction. Gene Ther. 6, 1045-1053